Tag Archives: PSI-7977

$INHX, inhibited?

Posted on September 1, 2011 by BioChef in Training

So, what do you do if you want to get some exposure in the hot HCV space? A space where competition is steep and filled with big-time players such as Roche, JNJ (Tibotec), Bristol-Myers, Merck, Boehringer, and even Pharmasset at … Continue reading →

Posted in Research | Tagged , , , , , , , , , , , , , | 2 Comments

No, I didn’t. Yes, $IDIX.

Posted on August 29, 2011 by BioChef in Training

A little late to the story, but what a ride for $IDIX over the course of the year. Source: Yahoo! Finance, 08-29-11 About this time last year, $IDIX was a $437 MM market cap company (c.73M shares outstanding x $5.99/share, … Continue reading →

Posted in Research | Tagged , , , , , , , , , , | 1 Comment